Inventor · disambiguated record
Erik Nordling
Also filed as: NORDLING ERIK
9 granted patents·6 pending applications·15 citations·filing 2005–2024
81Inventor score
Files withSWEDISH ORPHAN BIOVITRUM AB PUBL8AFFIBODY AB2EVANS DAVID2AKINION PHARMACEUTICALS AB1BARKER EMMA1
Top patents by PatentIndex Score
15 records- 0184US9982022B2Binding polypeptides having a mutated scaffoldAFFIBODY AB·Filed 2014·Granted May 29, 2018·5 cites·16 claims
- 0278US9994626B2Stable polypeptides binding to human complement C5SWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2014·Granted Jun 12, 2018·5 cites·14 claims
- 0374US2025066451A1Il-ir-i binding polypeptideSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2024·Application pending·0 cites
- 0472US9982243B2Modified sulfamidase and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2015·Granted May 29, 2018·3 cites·13 claims
- 0566US9150574B2Enzyme inhibitor compoundsEVANS DAVID·Filed 2011·Granted Oct 6, 2015·1 cites·12 claims
- 0665US9227967B2Inhibitor compounds of semicarbazide-sensitive amine oxidasesEVANS DAVID·Filed 2011·Granted Jan 5, 2016·1 cites·37 claims
- 0758USRE49495EBinding polypeptides having a mutated scaffoldAFFIBODY AB·Filed 2014·Granted Apr 18, 2023·0 cites·18 claims
- 0855US12116397B2IL-IR-I binding polypeptideSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Granted Oct 15, 2024·0 cites·25 claims
- 0953US8436171B2Amino substituted pyrazines as inhibitors or protein kinasesJENSEN ANNIKA JENMALM·Filed 2009·Granted May 7, 2013·0 cites·2 claims
- 1044US2013203774A1Novel compounds, use and preparation thereofAKINION PHARMACEUTICALS AB·Filed 2013·Application pending·0 cites
- 1140US11584778B2Fusion protein with half-life extending polypeptideSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Granted Feb 21, 2023·0 cites·18 claims
- 1240US2018320152A1Modified sulfamidase and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2018·Application pending·0 cites
- 1339US2006217375A1New compoundsBARKER EMMA·Filed 2005·Application pending·0 cites
- 1431US2018264089A1Modified iduronate 2-sulfatase and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2016·Application pending·0 cites
- 1527US2018258408A1Modified lysosomal protein and production thereofSWEDISH ORPHAN BIOVITRUM AB PUBL·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erik Nordling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →